nodes	percent_of_prediction	percent_of_DWPC	metapath
Dicyclomine—CHRM3—Carbachol—glaucoma	0.139	0.181	CbGbCtD
Dicyclomine—CHRM3—Pilocarpine—glaucoma	0.129	0.169	CbGbCtD
Dicyclomine—CHRM1—Carbachol—glaucoma	0.121	0.158	CbGbCtD
Dicyclomine—CHRM1—Pilocarpine—glaucoma	0.112	0.147	CbGbCtD
Dicyclomine—CHRM2—Carbachol—glaucoma	0.111	0.145	CbGbCtD
Dicyclomine—CHRM2—Pilocarpine—glaucoma	0.103	0.135	CbGbCtD
Dicyclomine—CYP1A1—Clonidine—glaucoma	0.05	0.0654	CbGbCtD
Dicyclomine—CYP1A1—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP1B1—glaucoma	0.00049	0.0415	CbGpPWpGaD
Dicyclomine—CYP1A1—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP1B1—glaucoma	0.000446	0.0378	CbGpPWpGaD
Dicyclomine—CYP1A1—Benzo(a)pyrene metabolism—CYP1B1—glaucoma	0.000446	0.0378	CbGpPWpGaD
Dicyclomine—CYP1A1—Estrogen Receptor Pathway—CYP1B1—glaucoma	0.000332	0.0282	CbGpPWpGaD
Dicyclomine—CHRM1—Circadian rythm related genes—ATOH7—glaucoma	0.000318	0.027	CbGpPWpGaD
Dicyclomine—Dyspnoea—Brimonidine—glaucoma	0.000279	0.00125	CcSEcCtD
Dicyclomine—Somnolence—Brimonidine—glaucoma	0.000279	0.00125	CcSEcCtD
Dicyclomine—Mental disorder—Clonidine—glaucoma	0.000278	0.00125	CcSEcCtD
Dicyclomine—Shock—Pilocarpine—glaucoma	0.000278	0.00124	CcSEcCtD
Dicyclomine—Erythema—Clonidine—glaucoma	0.000277	0.00124	CcSEcCtD
Dicyclomine—Tachycardia—Pilocarpine—glaucoma	0.000276	0.00123	CcSEcCtD
Dicyclomine—Dyspepsia—Brimonidine—glaucoma	0.000276	0.00123	CcSEcCtD
Dicyclomine—Hallucination—Betaxolol—glaucoma	0.000275	0.00123	CcSEcCtD
Dicyclomine—Hypoaesthesia—Betaxolol—glaucoma	0.000275	0.00123	CcSEcCtD
Dicyclomine—Tension—Clonidine—glaucoma	0.000272	0.00121	CcSEcCtD
Dicyclomine—Insomnia—Dorzolamide—glaucoma	0.000271	0.00121	CcSEcCtD
Dicyclomine—Gastrointestinal disorder—Brimonidine—glaucoma	0.000271	0.00121	CcSEcCtD
Dicyclomine—Fatigue—Brimonidine—glaucoma	0.00027	0.00121	CcSEcCtD
Dicyclomine—Anorexia—Pilocarpine—glaucoma	0.00027	0.00121	CcSEcCtD
Dicyclomine—Feeling abnormal—Acetazolamide—glaucoma	0.000269	0.0012	CcSEcCtD
Dicyclomine—Hypersensitivity—Apraclonidine—glaucoma	0.000269	0.0012	CcSEcCtD
Dicyclomine—Nervousness—Clonidine—glaucoma	0.000269	0.0012	CcSEcCtD
Dicyclomine—Paraesthesia—Dorzolamide—glaucoma	0.000269	0.0012	CcSEcCtD
Dicyclomine—Pain—Brimonidine—glaucoma	0.000268	0.0012	CcSEcCtD
Dicyclomine—Dyspnoea—Dorzolamide—glaucoma	0.000267	0.00119	CcSEcCtD
Dicyclomine—Insomnia—Brinzolamide—glaucoma	0.000266	0.00119	CcSEcCtD
Dicyclomine—Somnolence—Dorzolamide—glaucoma	0.000266	0.00119	CcSEcCtD
Dicyclomine—Dyspnoea—Travoprost—glaucoma	0.000266	0.00119	CcSEcCtD
Dicyclomine—Paraesthesia—Brinzolamide—glaucoma	0.000264	0.00118	CcSEcCtD
Dicyclomine—Dyspepsia—Dorzolamide—glaucoma	0.000263	0.00118	CcSEcCtD
Dicyclomine—Dyspnoea—Brinzolamide—glaucoma	0.000262	0.00117	CcSEcCtD
Dicyclomine—Dyspepsia—Travoprost—glaucoma	0.000262	0.00117	CcSEcCtD
Dicyclomine—Asthenia—Apraclonidine—glaucoma	0.000262	0.00117	CcSEcCtD
Dicyclomine—Somnolence—Brinzolamide—glaucoma	0.000262	0.00117	CcSEcCtD
Dicyclomine—Vision blurred—Clonidine—glaucoma	0.000261	0.00117	CcSEcCtD
Dicyclomine—Decreased appetite—Dorzolamide—glaucoma	0.00026	0.00116	CcSEcCtD
Dicyclomine—Erectile dysfunction—Timolol—glaucoma	0.00026	0.00116	CcSEcCtD
Dicyclomine—Urticaria—Acetazolamide—glaucoma	0.000259	0.00116	CcSEcCtD
Dicyclomine—Dyspepsia—Brinzolamide—glaucoma	0.000259	0.00116	CcSEcCtD
Dicyclomine—Eye disorder—Betaxolol—glaucoma	0.000259	0.00116	CcSEcCtD
Dicyclomine—Pruritus—Apraclonidine—glaucoma	0.000258	0.00116	CcSEcCtD
Dicyclomine—Fatigue—Dorzolamide—glaucoma	0.000258	0.00115	CcSEcCtD
Dicyclomine—Gastrointestinal disorder—Travoprost—glaucoma	0.000257	0.00115	CcSEcCtD
Dicyclomine—Fatigue—Travoprost—glaucoma	0.000257	0.00115	CcSEcCtD
Dicyclomine—Cardiac disorder—Betaxolol—glaucoma	0.000257	0.00115	CcSEcCtD
Dicyclomine—Ill-defined disorder—Clonidine—glaucoma	0.000257	0.00115	CcSEcCtD
Dicyclomine—CYP1A1—Estrogen metabolism—CYP1B1—glaucoma	0.000256	0.0217	CbGpPWpGaD
Dicyclomine—Pain—Dorzolamide—glaucoma	0.000256	0.00114	CcSEcCtD
Dicyclomine—Insomnia—Pilocarpine—glaucoma	0.000256	0.00114	CcSEcCtD
Dicyclomine—Decreased appetite—Brinzolamide—glaucoma	0.000256	0.00114	CcSEcCtD
Dicyclomine—Constipation—Travoprost—glaucoma	0.000255	0.00114	CcSEcCtD
Dicyclomine—Pain—Travoprost—glaucoma	0.000255	0.00114	CcSEcCtD
Dicyclomine—Agitation—Clonidine—glaucoma	0.000254	0.00114	CcSEcCtD
Dicyclomine—Gastrointestinal disorder—Brinzolamide—glaucoma	0.000254	0.00114	CcSEcCtD
Dicyclomine—Paraesthesia—Pilocarpine—glaucoma	0.000254	0.00114	CcSEcCtD
Dicyclomine—Asthenia—Bimatoprost—glaucoma	0.000254	0.00114	CcSEcCtD
Dicyclomine—Fatigue—Brinzolamide—glaucoma	0.000254	0.00113	CcSEcCtD
Dicyclomine—Angioedema—Clonidine—glaucoma	0.000253	0.00113	CcSEcCtD
Dicyclomine—Dyspnoea—Pilocarpine—glaucoma	0.000252	0.00113	CcSEcCtD
Dicyclomine—Pain—Brinzolamide—glaucoma	0.000252	0.00113	CcSEcCtD
Dicyclomine—Somnolence—Pilocarpine—glaucoma	0.000251	0.00112	CcSEcCtD
Dicyclomine—Pruritus—Bimatoprost—glaucoma	0.00025	0.00112	CcSEcCtD
Dicyclomine—Immune system disorder—Betaxolol—glaucoma	0.00025	0.00112	CcSEcCtD
Dicyclomine—Malaise—Clonidine—glaucoma	0.00025	0.00112	CcSEcCtD
Dicyclomine—Mediastinal disorder—Betaxolol—glaucoma	0.000249	0.00112	CcSEcCtD
Dicyclomine—Dyspepsia—Pilocarpine—glaucoma	0.000249	0.00111	CcSEcCtD
Dicyclomine—Syncope—Clonidine—glaucoma	0.000248	0.00111	CcSEcCtD
Dicyclomine—CHRM2—SIDS Susceptibility Pathways—LMX1B—glaucoma	0.000248	0.021	CbGpPWpGaD
Dicyclomine—Feeling abnormal—Dorzolamide—glaucoma	0.000247	0.0011	CcSEcCtD
Dicyclomine—Decreased appetite—Pilocarpine—glaucoma	0.000246	0.0011	CcSEcCtD
Dicyclomine—Feeling abnormal—Travoprost—glaucoma	0.000246	0.0011	CcSEcCtD
Dicyclomine—Gastrointestinal pain—Dorzolamide—glaucoma	0.000245	0.00109	CcSEcCtD
Dicyclomine—Palpitations—Clonidine—glaucoma	0.000245	0.00109	CcSEcCtD
Dicyclomine—Gastrointestinal disorder—Pilocarpine—glaucoma	0.000244	0.00109	CcSEcCtD
Dicyclomine—Gastrointestinal pain—Travoprost—glaucoma	0.000244	0.00109	CcSEcCtD
Dicyclomine—Loss of consciousness—Clonidine—glaucoma	0.000243	0.00109	CcSEcCtD
Dicyclomine—Feeling abnormal—Brinzolamide—glaucoma	0.000242	0.00108	CcSEcCtD
Dicyclomine—Mental disorder—Betaxolol—glaucoma	0.000242	0.00108	CcSEcCtD
Dicyclomine—Constipation—Pilocarpine—glaucoma	0.000242	0.00108	CcSEcCtD
Dicyclomine—Pain—Pilocarpine—glaucoma	0.000242	0.00108	CcSEcCtD
Dicyclomine—Dizziness—Apraclonidine—glaucoma	0.000241	0.00108	CcSEcCtD
Dicyclomine—Erythema—Betaxolol—glaucoma	0.000241	0.00108	CcSEcCtD
Dicyclomine—Urticaria—Dorzolamide—glaucoma	0.000238	0.00106	CcSEcCtD
Dicyclomine—Abdominal pain—Dorzolamide—glaucoma	0.000237	0.00106	CcSEcCtD
Dicyclomine—Tension—Betaxolol—glaucoma	0.000236	0.00106	CcSEcCtD
Dicyclomine—Abdominal pain—Travoprost—glaucoma	0.000236	0.00105	CcSEcCtD
Dicyclomine—Asthenia—Acetazolamide—glaucoma	0.000234	0.00105	CcSEcCtD
Dicyclomine—Dizziness—Bimatoprost—glaucoma	0.000234	0.00105	CcSEcCtD
Dicyclomine—Nervousness—Betaxolol—glaucoma	0.000234	0.00105	CcSEcCtD
Dicyclomine—Urticaria—Brinzolamide—glaucoma	0.000234	0.00105	CcSEcCtD
Dicyclomine—Feeling abnormal—Pilocarpine—glaucoma	0.000233	0.00104	CcSEcCtD
Dicyclomine—Discomfort—Clonidine—glaucoma	0.000233	0.00104	CcSEcCtD
Dicyclomine—Vomiting—Apraclonidine—glaucoma	0.000232	0.00104	CcSEcCtD
Dicyclomine—Gastrointestinal pain—Pilocarpine—glaucoma	0.000231	0.00103	CcSEcCtD
Dicyclomine—Hypersensitivity—Brimonidine—glaucoma	0.000231	0.00103	CcSEcCtD
Dicyclomine—Dry mouth—Clonidine—glaucoma	0.00023	0.00103	CcSEcCtD
Dicyclomine—Dermatitis—Apraclonidine—glaucoma	0.00023	0.00103	CcSEcCtD
Dicyclomine—Headache—Apraclonidine—glaucoma	0.000229	0.00102	CcSEcCtD
Dicyclomine—Confusional state—Clonidine—glaucoma	0.000228	0.00102	CcSEcCtD
Dicyclomine—Vision blurred—Betaxolol—glaucoma	0.000227	0.00102	CcSEcCtD
Dicyclomine—CYP1A1—Tamoxifen metabolism—CYP1B1—glaucoma	0.000226	0.0192	CbGpPWpGaD
Dicyclomine—Oedema—Clonidine—glaucoma	0.000226	0.00101	CcSEcCtD
Dicyclomine—Hallucination—Timolol—glaucoma	0.000225	0.00101	CcSEcCtD
Dicyclomine—Asthenia—Brimonidine—glaucoma	0.000225	0.00101	CcSEcCtD
Dicyclomine—Abdominal pain—Pilocarpine—glaucoma	0.000224	0.001	CcSEcCtD
Dicyclomine—Ill-defined disorder—Betaxolol—glaucoma	0.000224	0.001	CcSEcCtD
Dicyclomine—Rash—Bimatoprost—glaucoma	0.000223	0.000998	CcSEcCtD
Dicyclomine—Dermatitis—Bimatoprost—glaucoma	0.000223	0.000997	CcSEcCtD
Dicyclomine—Shock—Clonidine—glaucoma	0.000222	0.000994	CcSEcCtD
Dicyclomine—Pruritus—Brimonidine—glaucoma	0.000222	0.000992	CcSEcCtD
Dicyclomine—Headache—Bimatoprost—glaucoma	0.000222	0.000992	CcSEcCtD
Dicyclomine—Nervous system disorder—Clonidine—glaucoma	0.000221	0.000991	CcSEcCtD
Dicyclomine—Hypersensitivity—Dorzolamide—glaucoma	0.000221	0.000986	CcSEcCtD
Dicyclomine—Tachycardia—Clonidine—glaucoma	0.00022	0.000986	CcSEcCtD
Dicyclomine—Hypersensitivity—Travoprost—glaucoma	0.00022	0.000982	CcSEcCtD
Dicyclomine—Malaise—Betaxolol—glaucoma	0.000217	0.000972	CcSEcCtD
Dicyclomine—Nausea—Apraclonidine—glaucoma	0.000217	0.00097	CcSEcCtD
Dicyclomine—Hypersensitivity—Brinzolamide—glaucoma	0.000217	0.00097	CcSEcCtD
Dicyclomine—Syncope—Betaxolol—glaucoma	0.000216	0.000967	CcSEcCtD
Dicyclomine—Dizziness—Acetazolamide—glaucoma	0.000216	0.000966	CcSEcCtD
Dicyclomine—Anorexia—Clonidine—glaucoma	0.000215	0.000963	CcSEcCtD
Dicyclomine—Asthenia—Dorzolamide—glaucoma	0.000215	0.000961	CcSEcCtD
Dicyclomine—CHRM3—GPCRs, Other—PTGFR—glaucoma	0.000214	0.0182	CbGpPWpGaD
Dicyclomine—Asthenia—Travoprost—glaucoma	0.000214	0.000956	CcSEcCtD
Dicyclomine—Palpitations—Betaxolol—glaucoma	0.000213	0.000952	CcSEcCtD
Dicyclomine—CHRM2—GPCRs, Other—PTGFR—glaucoma	0.000212	0.018	CbGpPWpGaD
Dicyclomine—Pruritus—Dorzolamide—glaucoma	0.000212	0.000947	CcSEcCtD
Dicyclomine—Loss of consciousness—Betaxolol—glaucoma	0.000212	0.000947	CcSEcCtD
Dicyclomine—Eye disorder—Timolol—glaucoma	0.000211	0.000945	CcSEcCtD
Dicyclomine—Asthenia—Brinzolamide—glaucoma	0.000211	0.000944	CcSEcCtD
Dicyclomine—Pruritus—Travoprost—glaucoma	0.000211	0.000943	CcSEcCtD
Dicyclomine—Nausea—Bimatoprost—glaucoma	0.00021	0.00094	CcSEcCtD
Dicyclomine—Cardiac disorder—Timolol—glaucoma	0.00021	0.000939	CcSEcCtD
Dicyclomine—Hypersensitivity—Pilocarpine—glaucoma	0.000208	0.000932	CcSEcCtD
Dicyclomine—Pruritus—Brinzolamide—glaucoma	0.000208	0.000931	CcSEcCtD
Dicyclomine—Vomiting—Acetazolamide—glaucoma	0.000208	0.000929	CcSEcCtD
Dicyclomine—Dizziness—Brimonidine—glaucoma	0.000207	0.000927	CcSEcCtD
Dicyclomine—CYP1A1—Estrogen metabolism—GSTM1—glaucoma	0.000205	0.0173	CbGpPWpGaD
Dicyclomine—Headache—Acetazolamide—glaucoma	0.000205	0.000915	CcSEcCtD
Dicyclomine—Insomnia—Clonidine—glaucoma	0.000204	0.000914	CcSEcCtD
Dicyclomine—Immune system disorder—Timolol—glaucoma	0.000204	0.000914	CcSEcCtD
Dicyclomine—Mediastinal disorder—Timolol—glaucoma	0.000204	0.000912	CcSEcCtD
Dicyclomine—Asthenia—Pilocarpine—glaucoma	0.000203	0.000908	CcSEcCtD
Dicyclomine—Paraesthesia—Clonidine—glaucoma	0.000203	0.000907	CcSEcCtD
Dicyclomine—Discomfort—Betaxolol—glaucoma	0.000203	0.000907	CcSEcCtD
Dicyclomine—Dyspnoea—Clonidine—glaucoma	0.000201	0.000901	CcSEcCtD
Dicyclomine—Somnolence—Clonidine—glaucoma	0.000201	0.000898	CcSEcCtD
Dicyclomine—Dry mouth—Betaxolol—glaucoma	0.000201	0.000897	CcSEcCtD
Dicyclomine—Pruritus—Pilocarpine—glaucoma	0.0002	0.000895	CcSEcCtD
Dicyclomine—Confusional state—Betaxolol—glaucoma	0.000198	0.000887	CcSEcCtD
Dicyclomine—Mental disorder—Timolol—glaucoma	0.000198	0.000886	CcSEcCtD
Dicyclomine—Dizziness—Dorzolamide—glaucoma	0.000198	0.000885	CcSEcCtD
Dicyclomine—Rash—Brimonidine—glaucoma	0.000198	0.000884	CcSEcCtD
Dicyclomine—Dermatitis—Brimonidine—glaucoma	0.000197	0.000883	CcSEcCtD
Dicyclomine—Dizziness—Travoprost—glaucoma	0.000197	0.000882	CcSEcCtD
Dicyclomine—Erythema—Timolol—glaucoma	0.000197	0.00088	CcSEcCtD
Dicyclomine—Oedema—Betaxolol—glaucoma	0.000197	0.00088	CcSEcCtD
Dicyclomine—Headache—Brimonidine—glaucoma	0.000196	0.000878	CcSEcCtD
Dicyclomine—Decreased appetite—Clonidine—glaucoma	0.000196	0.000878	CcSEcCtD
Dicyclomine—Gastrointestinal disorder—Clonidine—glaucoma	0.000195	0.000872	CcSEcCtD
Dicyclomine—Fatigue—Clonidine—glaucoma	0.000195	0.000871	CcSEcCtD
Dicyclomine—Dizziness—Brinzolamide—glaucoma	0.000195	0.00087	CcSEcCtD
Dicyclomine—Nausea—Acetazolamide—glaucoma	0.000194	0.000868	CcSEcCtD
Dicyclomine—Shock—Betaxolol—glaucoma	0.000193	0.000865	CcSEcCtD
Dicyclomine—Tension—Timolol—glaucoma	0.000193	0.000864	CcSEcCtD
Dicyclomine—Pain—Clonidine—glaucoma	0.000193	0.000864	CcSEcCtD
Dicyclomine—Constipation—Clonidine—glaucoma	0.000193	0.000864	CcSEcCtD
Dicyclomine—Nervous system disorder—Betaxolol—glaucoma	0.000193	0.000863	CcSEcCtD
Dicyclomine—Tachycardia—Betaxolol—glaucoma	0.000192	0.000858	CcSEcCtD
Dicyclomine—Nervousness—Timolol—glaucoma	0.000191	0.000855	CcSEcCtD
Dicyclomine—Vomiting—Dorzolamide—glaucoma	0.00019	0.000851	CcSEcCtD
Dicyclomine—Rash—Dorzolamide—glaucoma	0.000189	0.000844	CcSEcCtD
Dicyclomine—Dermatitis—Dorzolamide—glaucoma	0.000189	0.000843	CcSEcCtD
Dicyclomine—Rash—Travoprost—glaucoma	0.000188	0.000841	CcSEcCtD
Dicyclomine—Dermatitis—Travoprost—glaucoma	0.000188	0.00084	CcSEcCtD
Dicyclomine—Headache—Dorzolamide—glaucoma	0.000187	0.000839	CcSEcCtD
Dicyclomine—Anorexia—Betaxolol—glaucoma	0.000187	0.000838	CcSEcCtD
Dicyclomine—Vomiting—Brinzolamide—glaucoma	0.000187	0.000837	CcSEcCtD
Dicyclomine—Dizziness—Pilocarpine—glaucoma	0.000187	0.000837	CcSEcCtD
Dicyclomine—Headache—Travoprost—glaucoma	0.000187	0.000835	CcSEcCtD
Dicyclomine—Nausea—Brimonidine—glaucoma	0.000186	0.000833	CcSEcCtD
Dicyclomine—Feeling abnormal—Clonidine—glaucoma	0.000186	0.000833	CcSEcCtD
Dicyclomine—Rash—Brinzolamide—glaucoma	0.000186	0.00083	CcSEcCtD
Dicyclomine—Vision blurred—Timolol—glaucoma	0.000185	0.00083	CcSEcCtD
Dicyclomine—Dermatitis—Brinzolamide—glaucoma	0.000185	0.000829	CcSEcCtD
Dicyclomine—Gastrointestinal pain—Clonidine—glaucoma	0.000185	0.000826	CcSEcCtD
Dicyclomine—Headache—Brinzolamide—glaucoma	0.000184	0.000825	CcSEcCtD
Dicyclomine—Angioedema—Timolol—glaucoma	0.00018	0.000805	CcSEcCtD
Dicyclomine—Vomiting—Pilocarpine—glaucoma	0.00018	0.000804	CcSEcCtD
Dicyclomine—Urticaria—Clonidine—glaucoma	0.000179	0.000803	CcSEcCtD
Dicyclomine—Abdominal pain—Clonidine—glaucoma	0.000179	0.000799	CcSEcCtD
Dicyclomine—Rash—Pilocarpine—glaucoma	0.000178	0.000798	CcSEcCtD
Dicyclomine—Dermatitis—Pilocarpine—glaucoma	0.000178	0.000797	CcSEcCtD
Dicyclomine—Insomnia—Betaxolol—glaucoma	0.000178	0.000796	CcSEcCtD
Dicyclomine—Nausea—Dorzolamide—glaucoma	0.000178	0.000795	CcSEcCtD
Dicyclomine—Headache—Pilocarpine—glaucoma	0.000177	0.000793	CcSEcCtD
Dicyclomine—Nausea—Travoprost—glaucoma	0.000177	0.000792	CcSEcCtD
Dicyclomine—Paraesthesia—Betaxolol—glaucoma	0.000177	0.00079	CcSEcCtD
Dicyclomine—Syncope—Timolol—glaucoma	0.000176	0.00079	CcSEcCtD
Dicyclomine—Dyspnoea—Betaxolol—glaucoma	0.000175	0.000784	CcSEcCtD
Dicyclomine—Nausea—Brinzolamide—glaucoma	0.000175	0.000782	CcSEcCtD
Dicyclomine—CYP1A1—Melatonin metabolism and effects—CYP1B1—glaucoma	0.000175	0.0148	CbGpPWpGaD
Dicyclomine—Palpitations—Timolol—glaucoma	0.000174	0.000778	CcSEcCtD
Dicyclomine—Dyspepsia—Betaxolol—glaucoma	0.000173	0.000774	CcSEcCtD
Dicyclomine—Loss of consciousness—Timolol—glaucoma	0.000173	0.000774	CcSEcCtD
Dicyclomine—Decreased appetite—Betaxolol—glaucoma	0.000171	0.000765	CcSEcCtD
Dicyclomine—Hypertension—Timolol—glaucoma	0.00017	0.00076	CcSEcCtD
Dicyclomine—Gastrointestinal disorder—Betaxolol—glaucoma	0.00017	0.000759	CcSEcCtD
Dicyclomine—Fatigue—Betaxolol—glaucoma	0.00017	0.000758	CcSEcCtD
Dicyclomine—Constipation—Betaxolol—glaucoma	0.000168	0.000752	CcSEcCtD
Dicyclomine—Pain—Betaxolol—glaucoma	0.000168	0.000752	CcSEcCtD
Dicyclomine—Nausea—Pilocarpine—glaucoma	0.000168	0.000751	CcSEcCtD
Dicyclomine—Hypersensitivity—Clonidine—glaucoma	0.000166	0.000744	CcSEcCtD
Dicyclomine—Discomfort—Timolol—glaucoma	0.000166	0.000741	CcSEcCtD
Dicyclomine—Dry mouth—Timolol—glaucoma	0.000164	0.000733	CcSEcCtD
Dicyclomine—Asthenia—Clonidine—glaucoma	0.000162	0.000725	CcSEcCtD
Dicyclomine—Feeling abnormal—Betaxolol—glaucoma	0.000162	0.000725	CcSEcCtD
Dicyclomine—Confusional state—Timolol—glaucoma	0.000162	0.000725	CcSEcCtD
Dicyclomine—Anaphylactic shock—Timolol—glaucoma	0.000161	0.000719	CcSEcCtD
Dicyclomine—Oedema—Timolol—glaucoma	0.000161	0.000719	CcSEcCtD
Dicyclomine—Pruritus—Clonidine—glaucoma	0.00016	0.000715	CcSEcCtD
Dicyclomine—Shock—Timolol—glaucoma	0.000158	0.000707	CcSEcCtD
Dicyclomine—Nervous system disorder—Timolol—glaucoma	0.000158	0.000705	CcSEcCtD
Dicyclomine—Urticaria—Betaxolol—glaucoma	0.000156	0.000699	CcSEcCtD
Dicyclomine—Anorexia—Timolol—glaucoma	0.000153	0.000685	CcSEcCtD
Dicyclomine—CYP1A1—Oxidative Stress—SOD1—glaucoma	0.000152	0.0129	CbGpPWpGaD
Dicyclomine—Dizziness—Clonidine—glaucoma	0.000149	0.000668	CcSEcCtD
Dicyclomine—Insomnia—Timolol—glaucoma	0.000145	0.00065	CcSEcCtD
Dicyclomine—Hypersensitivity—Betaxolol—glaucoma	0.000145	0.000648	CcSEcCtD
Dicyclomine—Paraesthesia—Timolol—glaucoma	0.000144	0.000645	CcSEcCtD
Dicyclomine—Vomiting—Clonidine—glaucoma	0.000144	0.000642	CcSEcCtD
Dicyclomine—Dyspnoea—Timolol—glaucoma	0.000143	0.000641	CcSEcCtD
Dicyclomine—Somnolence—Timolol—glaucoma	0.000143	0.000639	CcSEcCtD
Dicyclomine—Rash—Clonidine—glaucoma	0.000142	0.000637	CcSEcCtD
Dicyclomine—Dermatitis—Clonidine—glaucoma	0.000142	0.000636	CcSEcCtD
Dicyclomine—Headache—Clonidine—glaucoma	0.000141	0.000633	CcSEcCtD
Dicyclomine—Dyspepsia—Timolol—glaucoma	0.000141	0.000633	CcSEcCtD
Dicyclomine—CYP1A1—Melatonin metabolism and effects—EDN1—glaucoma	0.000141	0.012	CbGpPWpGaD
Dicyclomine—Asthenia—Betaxolol—glaucoma	0.000141	0.000631	CcSEcCtD
Dicyclomine—Decreased appetite—Timolol—glaucoma	0.00014	0.000625	CcSEcCtD
Dicyclomine—Pruritus—Betaxolol—glaucoma	0.000139	0.000622	CcSEcCtD
Dicyclomine—Gastrointestinal disorder—Timolol—glaucoma	0.000139	0.00062	CcSEcCtD
Dicyclomine—Fatigue—Timolol—glaucoma	0.000138	0.00062	CcSEcCtD
Dicyclomine—Pain—Timolol—glaucoma	0.000137	0.000614	CcSEcCtD
Dicyclomine—CHRM1—G alpha (q) signalling events—OPN4—glaucoma	0.000134	0.0114	CbGpPWpGaD
Dicyclomine—Nausea—Clonidine—glaucoma	0.000134	0.0006	CcSEcCtD
Dicyclomine—CHRM3—G alpha (q) signalling events—OPN4—glaucoma	0.000134	0.0113	CbGpPWpGaD
Dicyclomine—Feeling abnormal—Timolol—glaucoma	0.000132	0.000592	CcSEcCtD
Dicyclomine—Gastrointestinal pain—Timolol—glaucoma	0.000131	0.000588	CcSEcCtD
Dicyclomine—Dizziness—Betaxolol—glaucoma	0.00013	0.000582	CcSEcCtD
Dicyclomine—Urticaria—Timolol—glaucoma	0.000128	0.000571	CcSEcCtD
Dicyclomine—Abdominal pain—Timolol—glaucoma	0.000127	0.000568	CcSEcCtD
Dicyclomine—CHRM1—Circadian rythm related genes—OPN4—glaucoma	0.000127	0.0107	CbGpPWpGaD
Dicyclomine—Vomiting—Betaxolol—glaucoma	0.000125	0.000559	CcSEcCtD
Dicyclomine—Rash—Betaxolol—glaucoma	0.000124	0.000555	CcSEcCtD
Dicyclomine—Dermatitis—Betaxolol—glaucoma	0.000124	0.000554	CcSEcCtD
Dicyclomine—Headache—Betaxolol—glaucoma	0.000123	0.000551	CcSEcCtD
Dicyclomine—CHRM1—G alpha (q) signalling events—PTGFR—glaucoma	0.000121	0.0102	CbGpPWpGaD
Dicyclomine—CYP1A1—Tryptophan metabolism—CYP1B1—glaucoma	0.000121	0.0102	CbGpPWpGaD
Dicyclomine—CYP1A1—Aryl Hydrocarbon Receptor—CYP1B1—glaucoma	0.000121	0.0102	CbGpPWpGaD
Dicyclomine—CYP1A1—Aryl Hydrocarbon Receptor Pathway—CYP1B1—glaucoma	0.000121	0.0102	CbGpPWpGaD
Dicyclomine—CHRM3—G alpha (q) signalling events—PTGFR—glaucoma	0.00012	0.0102	CbGpPWpGaD
Dicyclomine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—OPN4—glaucoma	0.00012	0.0102	CbGpPWpGaD
Dicyclomine—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—OPN4—glaucoma	0.00012	0.0101	CbGpPWpGaD
Dicyclomine—CHRM1—Regulation of Actin Cytoskeleton—MYLK—glaucoma	0.00012	0.0101	CbGpPWpGaD
Dicyclomine—CHRM3—Regulation of Actin Cytoskeleton—MYLK—glaucoma	0.000119	0.0101	CbGpPWpGaD
Dicyclomine—Hypersensitivity—Timolol—glaucoma	0.000118	0.000529	CcSEcCtD
Dicyclomine—CHRM2—Regulation of Actin Cytoskeleton—MYLK—glaucoma	0.000118	0.01	CbGpPWpGaD
Dicyclomine—Nausea—Betaxolol—glaucoma	0.000117	0.000522	CcSEcCtD
Dicyclomine—Asthenia—Timolol—glaucoma	0.000115	0.000516	CcSEcCtD
Dicyclomine—CYP1A1—Melatonin metabolism and effects—APOE—glaucoma	0.000115	0.00975	CbGpPWpGaD
Dicyclomine—Pruritus—Timolol—glaucoma	0.000114	0.000508	CcSEcCtD
Dicyclomine—CHRM1—GPCRs, Class A Rhodopsin-like—MAS1—glaucoma	0.000113	0.00962	CbGpPWpGaD
Dicyclomine—CHRM3—GPCRs, Class A Rhodopsin-like—MAS1—glaucoma	0.000113	0.00959	CbGpPWpGaD
Dicyclomine—CYP1A1—Arachidonic acid metabolism—CYP1B1—glaucoma	0.000113	0.00958	CbGpPWpGaD
Dicyclomine—CHRM2—GPCRs, Class A Rhodopsin-like—MAS1—glaucoma	0.000112	0.0095	CbGpPWpGaD
Dicyclomine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—PTGFR—glaucoma	0.000108	0.00916	CbGpPWpGaD
Dicyclomine—CHRM3—GPCRs, Other—SMO—glaucoma	0.000108	0.00916	CbGpPWpGaD
Dicyclomine—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—PTGFR—glaucoma	0.000108	0.00914	CbGpPWpGaD
Dicyclomine—CHRM2—GPCRs, Other—SMO—glaucoma	0.000107	0.00908	CbGpPWpGaD
Dicyclomine—Dizziness—Timolol—glaucoma	0.000106	0.000475	CcSEcCtD
Dicyclomine—CHRM1—GPCRs, Class A Rhodopsin-like—OPN4—glaucoma	0.000104	0.0088	CbGpPWpGaD
Dicyclomine—CHRM3—GPCRs, Class A Rhodopsin-like—OPN4—glaucoma	0.000103	0.00877	CbGpPWpGaD
Dicyclomine—CHRM2—GPCRs, Class A Rhodopsin-like—OPN4—glaucoma	0.000102	0.00868	CbGpPWpGaD
Dicyclomine—Vomiting—Timolol—glaucoma	0.000102	0.000457	CcSEcCtD
Dicyclomine—Rash—Timolol—glaucoma	0.000101	0.000453	CcSEcCtD
Dicyclomine—Dermatitis—Timolol—glaucoma	0.000101	0.000453	CcSEcCtD
Dicyclomine—Headache—Timolol—glaucoma	0.000101	0.00045	CcSEcCtD
Dicyclomine—CYP1A1—Cytochrome P450 - arranged by substrate type—CYP1B1—glaucoma	9.77e-05	0.00828	CbGpPWpGaD
Dicyclomine—CYP1A1—Oxidation by Cytochrome P450—CYP1B1—glaucoma	9.64e-05	0.00817	CbGpPWpGaD
Dicyclomine—Nausea—Timolol—glaucoma	9.54e-05	0.000427	CcSEcCtD
Dicyclomine—CHRM1—GPCRs, Class A Rhodopsin-like—PTGFR—glaucoma	9.34e-05	0.00792	CbGpPWpGaD
Dicyclomine—CHRM3—GPCRs, Class A Rhodopsin-like—PTGFR—glaucoma	9.31e-05	0.0079	CbGpPWpGaD
Dicyclomine—CHRM2—GPCRs, Class A Rhodopsin-like—PTGFR—glaucoma	9.22e-05	0.00782	CbGpPWpGaD
Dicyclomine—CHRM1—Class A/1 (Rhodopsin-like receptors)—OPN4—glaucoma	8.89e-05	0.00754	CbGpPWpGaD
Dicyclomine—CHRM2—SIDS Susceptibility Pathways—HDAC9—glaucoma	8.89e-05	0.00754	CbGpPWpGaD
Dicyclomine—CHRM3—Class A/1 (Rhodopsin-like receptors)—OPN4—glaucoma	8.86e-05	0.00751	CbGpPWpGaD
Dicyclomine—CHRM2—Class A/1 (Rhodopsin-like receptors)—OPN4—glaucoma	8.78e-05	0.00744	CbGpPWpGaD
Dicyclomine—CHRM1—Class A/1 (Rhodopsin-like receptors)—PTGFR—glaucoma	8e-05	0.00679	CbGpPWpGaD
Dicyclomine—CHRM3—Class A/1 (Rhodopsin-like receptors)—PTGFR—glaucoma	7.98e-05	0.00676	CbGpPWpGaD
Dicyclomine—CYP1A1—Phase 1 - Functionalization of compounds—CYP1B1—glaucoma	7.92e-05	0.00671	CbGpPWpGaD
Dicyclomine—CHRM2—Class A/1 (Rhodopsin-like receptors)—PTGFR—glaucoma	7.9e-05	0.0067	CbGpPWpGaD
Dicyclomine—CHRM1—GPCR ligand binding—OPN4—glaucoma	6.77e-05	0.00574	CbGpPWpGaD
Dicyclomine—CHRM3—GPCR ligand binding—OPN4—glaucoma	6.75e-05	0.00572	CbGpPWpGaD
Dicyclomine—CHRM2—GPCR ligand binding—OPN4—glaucoma	6.68e-05	0.00567	CbGpPWpGaD
Dicyclomine—CHRM2—SIDS Susceptibility Pathways—NTRK2—glaucoma	6.36e-05	0.00539	CbGpPWpGaD
Dicyclomine—CHRM1—GPCR ligand binding—PTGFR—glaucoma	6.1e-05	0.00517	CbGpPWpGaD
Dicyclomine—CHRM3—GPCR ligand binding—PTGFR—glaucoma	6.08e-05	0.00515	CbGpPWpGaD
Dicyclomine—CHRM2—GPCR ligand binding—PTGFR—glaucoma	6.02e-05	0.0051	CbGpPWpGaD
Dicyclomine—CYP1A1—PPARA activates gene expression—ABCA1—glaucoma	6.02e-05	0.0051	CbGpPWpGaD
Dicyclomine—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—ABCA1—glaucoma	5.89e-05	0.00499	CbGpPWpGaD
Dicyclomine—CYP1A1—Aryl Hydrocarbon Receptor—PTGS2—glaucoma	5.45e-05	0.00462	CbGpPWpGaD
Dicyclomine—CYP1A1—Biological oxidations—GSTT1—glaucoma	5.28e-05	0.00448	CbGpPWpGaD
Dicyclomine—CYP1A1—Aryl Hydrocarbon Receptor Pathway—CDKN1B—glaucoma	5.16e-05	0.00437	CbGpPWpGaD
Dicyclomine—CYP1A1—Aryl Hydrocarbon Receptor—CDKN1B—glaucoma	5.16e-05	0.00437	CbGpPWpGaD
Dicyclomine—CYP1A1—Arachidonic acid metabolism—PTGS2—glaucoma	5.09e-05	0.00432	CbGpPWpGaD
Dicyclomine—CHRM2—SIDS Susceptibility Pathways—BDNF—glaucoma	4.75e-05	0.00403	CbGpPWpGaD
Dicyclomine—CHRM3—Metabolism—NARFL—glaucoma	4.66e-05	0.00395	CbGpPWpGaD
Dicyclomine—CHRM3—Metabolism—CA5A—glaucoma	4.66e-05	0.00395	CbGpPWpGaD
Dicyclomine—CHRM2—SIDS Susceptibility Pathways—IL1A—glaucoma	4.56e-05	0.00386	CbGpPWpGaD
Dicyclomine—CHRM1—Circadian rythm related genes—NGFR—glaucoma	4.51e-05	0.00383	CbGpPWpGaD
Dicyclomine—CYP1A1—Aryl Hydrocarbon Receptor—VEGFA—glaucoma	4.29e-05	0.00364	CbGpPWpGaD
Dicyclomine—CHRM1—Circadian rythm related genes—NTRK1—glaucoma	4.29e-05	0.00364	CbGpPWpGaD
Dicyclomine—CHRM2—SIDS Susceptibility Pathways—NGF—glaucoma	4.21e-05	0.00357	CbGpPWpGaD
Dicyclomine—CYP1A1—Biological oxidations—CYP1B1—glaucoma	4.21e-05	0.00357	CbGpPWpGaD
Dicyclomine—CHRM2—SIDS Susceptibility Pathways—NR3C1—glaucoma	4.19e-05	0.00356	CbGpPWpGaD
Dicyclomine—CYP1A1—Metapathway biotransformation—CYP1B1—glaucoma	4.15e-05	0.00352	CbGpPWpGaD
Dicyclomine—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—ABCA1—glaucoma	4.06e-05	0.00344	CbGpPWpGaD
Dicyclomine—CHRM1—G alpha (q) signalling events—EDN1—glaucoma	4.02e-05	0.00341	CbGpPWpGaD
Dicyclomine—CHRM3—G alpha (q) signalling events—EDN1—glaucoma	4.01e-05	0.0034	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism of lipids and lipoproteins—CTSA—glaucoma	3.93e-05	0.00333	CbGpPWpGaD
Dicyclomine—CHRM1—GPCR downstream signaling—OPN4—glaucoma	3.83e-05	0.00324	CbGpPWpGaD
Dicyclomine—CHRM3—GPCR downstream signaling—OPN4—glaucoma	3.81e-05	0.00323	CbGpPWpGaD
Dicyclomine—CHRM2—GPCR downstream signaling—OPN4—glaucoma	3.78e-05	0.0032	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism—NARFL—glaucoma	3.7e-05	0.00314	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism—CA5A—glaucoma	3.7e-05	0.00314	CbGpPWpGaD
Dicyclomine—CHRM1—Regulation of Actin Cytoskeleton—FN1—glaucoma	3.7e-05	0.00313	CbGpPWpGaD
Dicyclomine—CHRM3—Regulation of Actin Cytoskeleton—FN1—glaucoma	3.68e-05	0.00312	CbGpPWpGaD
Dicyclomine—CYP1A1—Aryl Hydrocarbon Receptor Pathway—TNF—glaucoma	3.68e-05	0.00312	CbGpPWpGaD
Dicyclomine—CYP1A1—Aryl Hydrocarbon Receptor—TNF—glaucoma	3.68e-05	0.00312	CbGpPWpGaD
Dicyclomine—CHRM2—Regulation of Actin Cytoskeleton—FN1—glaucoma	3.65e-05	0.00309	CbGpPWpGaD
Dicyclomine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—EDN1—glaucoma	3.59e-05	0.00305	CbGpPWpGaD
Dicyclomine—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—EDN1—glaucoma	3.58e-05	0.00304	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling by GPCR—OPN4—glaucoma	3.47e-05	0.00295	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling by GPCR—OPN4—glaucoma	3.46e-05	0.00294	CbGpPWpGaD
Dicyclomine—CHRM1—GPCR downstream signaling—PTGFR—glaucoma	3.44e-05	0.00292	CbGpPWpGaD
Dicyclomine—CHRM3—GPCR downstream signaling—PTGFR—glaucoma	3.43e-05	0.00291	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling by GPCR—OPN4—glaucoma	3.43e-05	0.00291	CbGpPWpGaD
Dicyclomine—CHRM2—GPCR downstream signaling—PTGFR—glaucoma	3.4e-05	0.00288	CbGpPWpGaD
Dicyclomine—CYP1A1—Biological oxidations—GSTM1—glaucoma	3.36e-05	0.00285	CbGpPWpGaD
Dicyclomine—CHRM1—Circadian rythm related genes—FAS—glaucoma	3.36e-05	0.00285	CbGpPWpGaD
Dicyclomine—CYP1A1—Metapathway biotransformation—GSTM1—glaucoma	3.32e-05	0.00281	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling by GPCR—PTGFR—glaucoma	3.13e-05	0.00265	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling by GPCR—PTGFR—glaucoma	3.12e-05	0.00264	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling by GPCR—PTGFR—glaucoma	3.09e-05	0.00262	CbGpPWpGaD
Dicyclomine—CHRM1—GPCR ligand binding—SMO—glaucoma	3.07e-05	0.00261	CbGpPWpGaD
Dicyclomine—CHRM3—GPCR ligand binding—SMO—glaucoma	3.06e-05	0.0026	CbGpPWpGaD
Dicyclomine—CHRM2—GPCR ligand binding—SMO—glaucoma	3.03e-05	0.00257	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—LRP12—glaucoma	2.96e-05	0.00251	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—LRP12—glaucoma	2.95e-05	0.0025	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—LRP12—glaucoma	2.92e-05	0.00248	CbGpPWpGaD
Dicyclomine—CHRM2—G alpha (i) signalling events—C3—glaucoma	2.89e-05	0.00245	CbGpPWpGaD
Dicyclomine—CHRM1—Class A/1 (Rhodopsin-like receptors)—EDN1—glaucoma	2.66e-05	0.00226	CbGpPWpGaD
Dicyclomine—CHRM3—Class A/1 (Rhodopsin-like receptors)—EDN1—glaucoma	2.65e-05	0.00225	CbGpPWpGaD
Dicyclomine—CHRM2—Class A/1 (Rhodopsin-like receptors)—EDN1—glaucoma	2.63e-05	0.00223	CbGpPWpGaD
Dicyclomine—CHRM1—Class A/1 (Rhodopsin-like receptors)—C3—glaucoma	2.32e-05	0.00197	CbGpPWpGaD
Dicyclomine—CHRM3—Class A/1 (Rhodopsin-like receptors)—C3—glaucoma	2.32e-05	0.00196	CbGpPWpGaD
Dicyclomine—CHRM2—Class A/1 (Rhodopsin-like receptors)—C3—glaucoma	2.29e-05	0.00195	CbGpPWpGaD
Dicyclomine—CHRM3—Metabolism—CA1—glaucoma	2.27e-05	0.00193	CbGpPWpGaD
Dicyclomine—CHRM3—Metabolism—CTSA—glaucoma	2.2e-05	0.00187	CbGpPWpGaD
Dicyclomine—CHRM3—Metabolism—CA2—glaucoma	2.08e-05	0.00176	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—OPN4—glaucoma	2.05e-05	0.00174	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—OPN4—glaucoma	2.05e-05	0.00173	CbGpPWpGaD
Dicyclomine—CHRM1—GPCR ligand binding—EDN1—glaucoma	2.03e-05	0.00172	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—OPN4—glaucoma	2.03e-05	0.00172	CbGpPWpGaD
Dicyclomine—CHRM3—GPCR ligand binding—EDN1—glaucoma	2.02e-05	0.00171	CbGpPWpGaD
Dicyclomine—CHRM2—SIDS Susceptibility Pathways—VEGFA—glaucoma	2.01e-05	0.00171	CbGpPWpGaD
Dicyclomine—CHRM2—GPCR ligand binding—EDN1—glaucoma	2e-05	0.0017	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—HEYL—glaucoma	1.91e-05	0.00162	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—HEYL—glaucoma	1.9e-05	0.00161	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—HEYL—glaucoma	1.88e-05	0.0016	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—PTGFR—glaucoma	1.85e-05	0.00157	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—PTGFR—glaucoma	1.84e-05	0.00156	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—PTGFR—glaucoma	1.82e-05	0.00155	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism—CA1—glaucoma	1.81e-05	0.00153	CbGpPWpGaD
Dicyclomine—CHRM1—GPCR ligand binding—C3—glaucoma	1.77e-05	0.0015	CbGpPWpGaD
Dicyclomine—CHRM3—GPCR ligand binding—C3—glaucoma	1.76e-05	0.0015	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism—CTSA—glaucoma	1.75e-05	0.00148	CbGpPWpGaD
Dicyclomine—CHRM2—GPCR ligand binding—C3—glaucoma	1.75e-05	0.00148	CbGpPWpGaD
Dicyclomine—CHRM2—SIDS Susceptibility Pathways—TNF—glaucoma	1.73e-05	0.00146	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism—CA2—glaucoma	1.65e-05	0.0014	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	1.62e-05	0.00137	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	1.62e-05	0.00137	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling by GPCR—SMO—glaucoma	1.58e-05	0.00134	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling by GPCR—SMO—glaucoma	1.57e-05	0.00133	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling by GPCR—SMO—glaucoma	1.56e-05	0.00132	CbGpPWpGaD
Dicyclomine—CHRM3—Metabolism—TXN—glaucoma	1.47e-05	0.00124	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—RPTOR—glaucoma	1.45e-05	0.00123	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—RPTOR—glaucoma	1.44e-05	0.00122	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—RPTOR—glaucoma	1.43e-05	0.00121	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—NCK2—glaucoma	1.4e-05	0.00119	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—NCK2—glaucoma	1.4e-05	0.00118	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—NCK2—glaucoma	1.38e-05	0.00117	CbGpPWpGaD
Dicyclomine—CHRM1—Circadian rythm related genes—TP53—glaucoma	1.26e-05	0.00107	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—HDAC9—glaucoma	1.19e-05	0.00101	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—HDAC9—glaucoma	1.19e-05	0.00101	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—HDAC9—glaucoma	1.18e-05	0.000997	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism—TXN—glaucoma	1.16e-05	0.000987	CbGpPWpGaD
Dicyclomine—CHRM1—GPCR downstream signaling—EDN1—glaucoma	1.15e-05	0.000971	CbGpPWpGaD
Dicyclomine—CHRM3—GPCR downstream signaling—EDN1—glaucoma	1.14e-05	0.000968	CbGpPWpGaD
Dicyclomine—CHRM3—Metabolism—GSTT1—glaucoma	1.14e-05	0.000964	CbGpPWpGaD
Dicyclomine—CHRM2—GPCR downstream signaling—EDN1—glaucoma	1.13e-05	0.000958	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism of lipids and lipoproteins—APOE—glaucoma	1.06e-05	0.000901	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism of lipids and lipoproteins—CAV1—glaucoma	1.05e-05	0.000892	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling by GPCR—EDN1—glaucoma	1.04e-05	0.000882	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling by GPCR—EDN1—glaucoma	1.04e-05	0.000879	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling by GPCR—EDN1—glaucoma	1.03e-05	0.00087	CbGpPWpGaD
Dicyclomine—CHRM1—GPCR downstream signaling—C3—glaucoma	1e-05	0.000848	CbGpPWpGaD
Dicyclomine—CHRM3—GPCR downstream signaling—C3—glaucoma	9.97e-06	0.000845	CbGpPWpGaD
Dicyclomine—CHRM2—GPCR downstream signaling—C3—glaucoma	9.88e-06	0.000837	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—SMO—glaucoma	9.32e-06	0.00079	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—SMO—glaucoma	9.29e-06	0.000787	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—SMO—glaucoma	9.2e-06	0.00078	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling by GPCR—C3—glaucoma	9.09e-06	0.00077	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling by GPCR—C3—glaucoma	9.06e-06	0.000768	CbGpPWpGaD
Dicyclomine—CHRM3—Metabolism—CYP1B1—glaucoma	9.06e-06	0.000768	CbGpPWpGaD
Dicyclomine—CHRM3—Metabolism—ABCA1—glaucoma	9.06e-06	0.000768	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism—GSTT1—glaucoma	9.03e-06	0.000765	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling by GPCR—C3—glaucoma	8.97e-06	0.00076	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—NTRK2—glaucoma	8.52e-06	0.000723	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—NTRK2—glaucoma	8.5e-06	0.00072	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—NTRK2—glaucoma	8.41e-06	0.000713	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—NGFR—glaucoma	7.31e-06	0.00062	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—NGFR—glaucoma	7.29e-06	0.000618	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	7.28e-06	0.000617	CbGpPWpGaD
Dicyclomine—CHRM3—Metabolism—GSTM1—glaucoma	7.24e-06	0.000614	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—NGFR—glaucoma	7.22e-06	0.000612	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism—CYP1B1—glaucoma	7.19e-06	0.00061	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism—ABCA1—glaucoma	7.19e-06	0.00061	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—NTRK1—glaucoma	6.95e-06	0.000589	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—NTRK1—glaucoma	6.93e-06	0.000587	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—NTRK1—glaucoma	6.86e-06	0.000581	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—CDKN2B—glaucoma	6.4e-06	0.000543	CbGpPWpGaD
Dicyclomine—CHRM3—Metabolism—MTHFR—glaucoma	6.4e-06	0.000542	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—CDKN2B—glaucoma	6.38e-06	0.000541	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—CDKN2B—glaucoma	6.32e-06	0.000536	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—EDN1—glaucoma	6.14e-06	0.000521	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—EDN1—glaucoma	6.12e-06	0.000519	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—EDN1—glaucoma	6.06e-06	0.000514	CbGpPWpGaD
Dicyclomine—CHRM3—Metabolism—APOE—glaucoma	5.96e-06	0.000505	CbGpPWpGaD
Dicyclomine—CHRM3—Metabolism—CAV1—glaucoma	5.9e-06	0.0005	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism—GSTM1—glaucoma	5.75e-06	0.000488	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—NGF—glaucoma	5.65e-06	0.000479	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—NGF—glaucoma	5.63e-06	0.000477	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—NGF—glaucoma	5.57e-06	0.000472	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—C3—glaucoma	5.37e-06	0.000455	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—C3—glaucoma	5.35e-06	0.000454	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—C3—glaucoma	5.3e-06	0.000449	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism—MTHFR—glaucoma	5.08e-06	0.000431	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—APOE—glaucoma	5e-06	0.000424	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—APOE—glaucoma	4.98e-06	0.000422	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—CAV1—glaucoma	4.95e-06	0.00042	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—CAV1—glaucoma	4.93e-06	0.000418	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—APOE—glaucoma	4.93e-06	0.000418	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—CAV1—glaucoma	4.89e-06	0.000414	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism—APOE—glaucoma	4.73e-06	0.000401	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—FN1—glaucoma	4.71e-06	0.000399	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—FN1—glaucoma	4.7e-06	0.000398	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism—CAV1—glaucoma	4.69e-06	0.000397	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—BAD—glaucoma	4.66e-06	0.000395	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—FN1—glaucoma	4.65e-06	0.000394	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—BAD—glaucoma	4.64e-06	0.000393	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—BAD—glaucoma	4.6e-06	0.00039	CbGpPWpGaD
Dicyclomine—CHRM3—Metabolism—NOS3—glaucoma	4.46e-06	0.000378	CbGpPWpGaD
Dicyclomine—CHRM3—Metabolism—PTGS2—glaucoma	4.08e-06	0.000346	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—NOS3—glaucoma	3.74e-06	0.000317	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—NOS3—glaucoma	3.73e-06	0.000316	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—NOS3—glaucoma	3.7e-06	0.000313	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism—NOS3—glaucoma	3.55e-06	0.000301	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—CDKN1B—glaucoma	3.24e-06	0.000275	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism—PTGS2—glaucoma	3.24e-06	0.000275	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—CDKN1B—glaucoma	3.23e-06	0.000274	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—CDKN1B—glaucoma	3.2e-06	0.000271	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—MMP9—glaucoma	3e-06	0.000255	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—MMP9—glaucoma	2.99e-06	0.000254	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—MMP9—glaucoma	2.96e-06	0.000251	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—VEGFA—glaucoma	2.7e-06	0.000229	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—VEGFA—glaucoma	2.69e-06	0.000228	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—VEGFA—glaucoma	2.66e-06	0.000226	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—TP53—glaucoma	2.04e-06	0.000173	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—TP53—glaucoma	2.03e-06	0.000172	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—TP53—glaucoma	2.01e-06	0.000171	CbGpPWpGaD
